BR9809137A - Métodos e composições para identificar suìnos geneticamente resistentes a doenças associadas a e. coli f18 - Google Patents

Métodos e composições para identificar suìnos geneticamente resistentes a doenças associadas a e. coli f18

Info

Publication number
BR9809137A
BR9809137A BR9809137-9A BR9809137A BR9809137A BR 9809137 A BR9809137 A BR 9809137A BR 9809137 A BR9809137 A BR 9809137A BR 9809137 A BR9809137 A BR 9809137A
Authority
BR
Brazil
Prior art keywords
coli
pigs
resistant
compositions
diseases associated
Prior art date
Application number
BR9809137-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Brad T Bosworth
Peter Voegeli
Original Assignee
Biotechnology Res & Dev
Us Agriculture
Swiss Fed Inst Of Tech Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21947500&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9809137(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotechnology Res & Dev, Us Agriculture, Swiss Fed Inst Of Tech Zuerich filed Critical Biotechnology Res & Dev
Publication of BR9809137A publication Critical patent/BR9809137A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
BR9809137-9A 1997-05-20 1998-05-20 Métodos e composições para identificar suìnos geneticamente resistentes a doenças associadas a e. coli f18 BR9809137A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4718197P 1997-05-20 1997-05-20
PCT/US1998/010318 WO1998053102A1 (en) 1997-05-20 1998-05-20 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases

Publications (1)

Publication Number Publication Date
BR9809137A true BR9809137A (pt) 2000-08-08

Family

ID=21947500

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809137-9A BR9809137A (pt) 1997-05-20 1998-05-20 Métodos e composições para identificar suìnos geneticamente resistentes a doenças associadas a e. coli f18

Country Status (21)

Country Link
US (3) US6596923B1 (enExample)
EP (1) EP0985052B1 (enExample)
JP (2) JP3637420B2 (enExample)
CN (1) CN1314953A (enExample)
AT (2) ATE246731T1 (enExample)
AU (2) AU7580798A (enExample)
BR (1) BR9809137A (enExample)
CA (1) CA2290768C (enExample)
CZ (1) CZ298021B6 (enExample)
DE (3) DE985052T1 (enExample)
DK (2) DK1310570T3 (enExample)
ES (2) ES2203958T3 (enExample)
HK (1) HK1040097A1 (enExample)
HU (1) HUP0103587A3 (enExample)
MX (1) MXPA99011988A (enExample)
NO (1) NO996373L (enExample)
NZ (1) NZ501886A (enExample)
PL (1) PL195890B1 (enExample)
PT (1) PT985052E (enExample)
RU (1) RU2204609C2 (enExample)
WO (2) WO1998053101A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355859B1 (en) * 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
PL195890B1 (pl) * 1997-05-20 2007-11-30 Biotechnology Res & Dev Sposoby identyfikacji świni odpornej na kolonizację jelit przez E. coli F18 lub zaburzenia jelitowezwiązane z E. coli F18, izolowane cząsteczki DNA,polipeptyd, polinukleotyd, oznaczenie molekularnedo wykrywania receptorów E. coli F18, zestaw do wykrywania receptorów E. coli F18 i zastosowanie zmutowanej postaci genu alfa (1,2)fukozylotransferazy 1 świni
HU221664B1 (hu) * 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
GB0118549D0 (en) * 2001-07-30 2001-09-19 Pig Improvement Uk Ltd Methods
AU2003281988B2 (en) 2002-11-25 2008-06-12 University Of Copenhagen Porcine polymorphisms and methods for detecting them
CA2512110A1 (en) 2002-12-31 2004-07-22 Mmi Genomics, Inc. Compositions, methods, and systems for inferring bovine breed
CN104982387B (zh) * 2015-05-25 2018-01-23 广东温氏食品集团股份有限公司 一种muc13和fut1基因的分子标记辅助选择方法
US10933121B2 (en) * 2015-09-02 2021-03-02 Dupont Nutrition Biosciences Aps Glycoside hydrolases and their use in preventing and/or treating a pathogenic infection in an animal
CN106480174B (zh) * 2016-09-14 2019-04-16 扬州大学 一种用于猪抗病育种的遗传分子标记方法和应用
CN108384865A (zh) * 2018-02-07 2018-08-10 扬州大学 Alpha菌毛基因在仔猪腹泻致病性大肠杆菌监测、鉴别中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK41885A (da) 1985-01-31 1986-11-13 Slagteriernes Forskningsinst 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen
DE69108568T3 (de) 1990-12-21 2004-03-04 The University Of Toronto Innovations Foundation, Toronto Diagnose für bösartige hyperthermia im schwein.
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5552144A (en) 1992-01-22 1996-09-03 Microcarb, Inc. Immunogenic shiga-like toxin II variant mutants
AU5715194A (en) 1992-12-04 1994-07-04 N.V. Innogenetics S.A. New polypeptides, nucleic acid sequences encoding them, and their use to prevent the adhesion of f107-fimbriated bacteria
US5625124A (en) * 1994-07-11 1997-04-29 Washington University Animal model for helicobacter pylori infection
WO1996028967A1 (en) 1995-03-17 1996-09-26 Chihiro Koike Transgenic non-primatal mammals wherein serotypes of higher primates have been expressed by foreign gene transfer and method of creating the same
US6355859B1 (en) * 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
PL195890B1 (pl) * 1997-05-20 2007-11-30 Biotechnology Res & Dev Sposoby identyfikacji świni odpornej na kolonizację jelit przez E. coli F18 lub zaburzenia jelitowezwiązane z E. coli F18, izolowane cząsteczki DNA,polipeptyd, polinukleotyd, oznaczenie molekularnedo wykrywania receptorów E. coli F18, zestaw do wykrywania receptorów E. coli F18 i zastosowanie zmutowanej postaci genu alfa (1,2)fukozylotransferazy 1 świni
WO2000056679A1 (en) * 1999-03-19 2000-09-28 Stonecraft, Llc Polymer-cement composites and methods of making same

Also Published As

Publication number Publication date
US6596923B1 (en) 2003-07-22
DK1310570T3 (da) 2006-02-13
US7193072B2 (en) 2007-03-20
PL364701A1 (en) 2004-12-13
JP3941956B2 (ja) 2007-07-11
HUP0103587A3 (en) 2006-02-28
DE69832306T2 (de) 2006-06-01
WO1998053101A3 (en) 1999-02-25
DE69816987D1 (de) 2003-09-11
DE69816987T2 (de) 2004-07-08
US20020133836A1 (en) 2002-09-19
WO1998053101A2 (en) 1998-11-26
CZ298021B6 (cs) 2007-05-30
RU2204609C2 (ru) 2003-05-20
CN1314953A (zh) 2001-09-26
ATE309392T1 (de) 2005-11-15
JP2001521401A (ja) 2001-11-06
PL195890B1 (pl) 2007-11-30
DK0985052T3 (da) 2003-10-27
WO1998053102A1 (en) 1998-11-26
AU7583298A (en) 1998-12-11
HUP0103587A1 (hu) 2002-01-28
US6965022B2 (en) 2005-11-15
ES2203958T3 (es) 2004-04-16
US20020129395A1 (en) 2002-09-12
CA2290768C (en) 2008-01-15
NZ501886A (en) 2001-07-27
CA2290768A1 (en) 1998-11-26
AU7580798A (en) 1998-12-11
NO996373D0 (no) 1999-12-21
JP3637420B2 (ja) 2005-04-13
CZ9904607A3 (cs) 2000-10-11
EP0985052B1 (en) 2003-08-06
AU737862B2 (en) 2001-08-30
DE69832306D1 (de) 2005-12-15
DE985052T1 (de) 2002-01-17
ATE246731T1 (de) 2003-08-15
ES2248647T3 (es) 2006-03-16
PT985052E (pt) 2003-11-28
JP2005058240A (ja) 2005-03-10
NO996373L (no) 2000-02-15
MXPA99011988A (es) 2004-05-21
HK1040097A1 (zh) 2002-05-24
EP0985052A1 (en) 2000-03-15

Similar Documents

Publication Publication Date Title
Teich et al. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants
Lu et al. Genomics of the periinfarction cortex after focal cerebral ischemia
Coronas et al. Identification and localization of dopamine receptor subtypes in rat olfactory mucosa and bulb: a combined in situ hybridization and ligand binding radioautographic approach
Loomes et al. Dll3 and Notch1 genetic interactions model axial segmental and craniofacial malformations of human birth defects
Wittekindt et al. The human small conductance calcium-regulated potassium channel gene (hSKCa3) contains two CAG repeats in exon 1, is on chromosome 1q21. 3, and shows a possible association with schizophrenia
PT985052E (pt) Metodos e composicoes para a identificacao de suinos geneticamente resistentes a doencas associadas a e.coli f18
Morrone et al. Asymptomatic dystrophinopathy
DE60328959D1 (de) Auswahl von Tieren für gewünschte genotypische und potentielle phänotypische Eigenschaften auf der Basis eines einzelnen Nukleotidpolymorphismus (SNP) im Intron 3 des IGF2-Gens
Schaeffel et al. Molecular biology of myopia §
Joyce Origins of cognitive dysfunction in schizophrenia: clues from age at onset
Edman Ahlbom et al. Deletion of chromosome 21 in a girl with congenital hypothyroidism and mild mental retardation
Driscoll et al. PCR assay for screening patients at risk for 22q11. 2 deletion
JP2006524690A (ja) 高インシュリン血症およびタイプii糖尿病の診断ならびにこれらに対する予防
CA2804923C (en) Assays for detecting wdr62 mutations
BR9813813A (pt) Sequência de dna, processo para proteger um paciente, peptìdio de sinal, anticorpo, imunoensaio, processo para diagnosticar uma prédisposição, processo para tratar um paciente humano, animal transgênico e linha de células
KR101849684B1 (ko) 샤르코-마리-투스병 제2형의 원인 유전자로서 morc2 및 이를 이용한 상기 질병의 진단방법
WO2017039028A1 (ko) 선천성 녹내장, 유전성 혈관 석회화 또는 골격 이상증에 대한 원인 유전자로서의 ddx58 돌연변이 유전자 및 이를 이용한 상기 질병의 진단방법 및 진단용 조성물
WO2007071437A2 (en) Compositions and methods for treating inflammatory disorders
EP3321374A1 (en) Shar-pei auto inflammatory disease in shar-pei dogs
US20060142233A1 (en) Gene expression and genetic changes implicated in alcoholism
US6855497B2 (en) DNA test for SCA-10
WO2022025299A1 (ja) 疾患罹患性の評価方法
Gunn Haploinsufficiency of the human myelin basic protein gene and central nervous system dysmyelination
KR20210121802A (ko) Mrgprx2를 이용한 즉시형 과민 반응 환자를 판별하는 방법
Wilbe Genetic association of Canine Lymphocytic Thyroiditis (CLT) with DLA class II in Giant Schnauzer and Hovawart dogs

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: O DEPOSITANTE DEIXOU DE APRESENTAR MANIFESTACAO SOBRE O PARECER NEGATIVO DE FOLHAS 128 A 132 PUBLICADO NA RPI N.O 1975, DE 11/11/2008. ASSIM, DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. PORTANTO, INDEFIRO O PRESENTE PEDIDO.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.